Ignite Creation Date:
2025-12-25 @ 3:49 AM
Ignite Modification Date:
2026-02-27 @ 3:13 AM
Study NCT ID:
NCT06785402
Status:
RECRUITING
Last Update Posted:
2025-12-02
First Post:
2025-01-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ceftriaxone for Post-Treatment Lyme Disease
Sponsor:
Hackensack Meridian Health
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Pro2024-0373
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |